Aprepilant Capsules

Founded in Mumbai(India), our company has been successful in capturing the local and domestic markets as trader of this product Catering to the ever-evolving packaging requirements of the clients, we make certain that our professionals use only the finest packaging material to circumvent loss during transit.

Features : High bioavailability Long shelf life Fast results High effectiveness Indication: Aprecap is also indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose. Aprecap in combination with other antiemetic agents is indicated to prevent nausea and vomiting caused by cancer chemotherapy treatment.

Available as : 125 mg (1 capsule) & 80 mg (2 capsules)